Molecular structure of Nedaplatin, CAS Number: 95734-82-0
Nedaplatin (CAS 95734-82-0)
Application:
Nedaplatin is a platinum complex that has potent antineoplatic activity
CAS Number:
95734-82-0
Molecular Weight:
303.2
Molecular Formula:
C2H8N2O3Pt
Supplemental Information:
This is as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Nedaplatin is a platinum complex that has potent antineoplastic activity.
Nedaplatin (CAS 95734-82-0) References
- Thyroid collision tumour with pulmonary metastases treated effectively with nedaplatin and paclitaxel chemotherapy: A case report. | Liu, F., et al. 2023. J Int Med Res. 51: 3000605231208602. PMID: 37929821
- Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report. | Wu, M., et al. 2023. AME Case Rep. 7: 32. PMID: 37942039
- Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study). | Yang, Y., et al. 2024. Int J Surg. 110: 1430-1440. PMID: 38051925
- Efficacy and safety of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin for advanced esophageal squamous cell carcinoma. | Yan, F., et al. 2024. Immunotherapy. 16: 305-317. PMID: 38197157
- Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma post-surgery. | Li, C., et al. 2024. J Cardiothorac Surg. 19: 26. PMID: 38273405
- Case report: A kidney metastasis from vulvar squamous cell carcinoma. | He, J., et al. 2023. Front Oncol. 13: 1280531. PMID: 38293696
- Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction: A Case Report. | Endo, Y., et al. 2024. In Vivo. 38: 958-962. PMID: 38418162
- Radiation-Induced Myonecrosis: A Case Report of a Cervical Cancer Patient With a History of Systemic Lupus Erythematosus. | Yamada, S., et al. 2024. Cureus. 16: e55134. PMID: 38558683
- Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial. | Wu, Z., et al. 2024. EClinicalMedicine. 71: 102579. PMID: 38618203
- Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review). | Xia, T. and Zhu, R. 2024. Biomed Rep. 20: 82. PMID: 38628627
- The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma. | He, Z., et al. 2024. Front Biosci (Landmark Ed). 29: 158. PMID: 38682206
- Case report: Pilomatrix carcinoma with PDL1 expression and CDKN2A aberrant. | Abula, A., et al. 2024. Front Immunol. 15: 1337400. PMID: 38873609
- Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model. | Uchida, N., et al. 1998. Anticancer Res. 18: 3375-9. PMID: 9858911
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Nedaplatin, 10 mg | sc-202238 | 10 mg | $117.00 | |||
Nedaplatin, 25 mg | sc-202238A | 25 mg | $348.00 |